As I see it if we use the 4.6M number for 10%:
Luye pays 4.6 for 10% - goes to 20% CASH goes to NUSEP
New instos pay 4.6 for 10% CASH goes to NUSEP
Us shareholders get 1 for 5 for 50% - NO CASH
Nusep holds 10% - NO CASH
IPO 10% - NO CASH for Nusep, CASH goes to PriMe
So Nusep gets 9.2M cash, PriMe Biologics get 4.6M in cash which is no where near enough for the plant unless I'm mistaken. One wrinkle is if Luye and Instos subscribe for shares in Prime then Nusep is diluted but presumably its 70% stake is valued higher, so the spin-off shares trap that value?
What will Nusep do with 9.2M cash? Spermsep? New investment in separation technology...? more questions...
As I see it if we use the 4.6M number for 10%:Luye pays 4.6 for...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.002(50.0%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $47.00K | 9.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1699939 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 5372603 | 4 |
View Market Depth
| Last trade - 13.59pm 14/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
